Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

Phase 4

Completed

• Conditions: Eyelid Diseases

• Registration Number: NCT01091311
• Lead Sponsor: Laboratoires Thea

Brief Summary

Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction .

Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.

This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.

Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-03-19
• Study First Submitted QC: 2010-03-21
• Study First Posted: 2010-03-24
• Study Start: 2010-05
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2011-06
• Last Update Submitted: 2011-06-07
• Last Update Posted: 2011-06-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (3)

C.H.N.O des XV-XX; 🇫🇷 Paris, France

Hôpital Bichat - Claude Bernard; 🇫🇷 Paris, France

Hôpital Gabriel Montpied; 🇫🇷 Clermont-Ferrand, France